Note 2 - Acquisition of M.C. Healthcare Products Inc. (Detail) - Pro-Forma Information (USD $)	12 Months Ended
Sep. 29, 2012	Oct. 01, 2011
Pro-forma net revenues	$ 78,540,000	$ 64,890,000
Pro-forma net income	$ 5,350,000	$ 4,770,000
Pro-forma net income per diluted share (in Dollars per share)	$ 1.81	$ 1.62

The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (h)(2)-(3)

-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1392-128463

+ Details

Name:	us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.

+ References

+ Details

Name:	us-gaap_BusinessAcquisitionsProFormaRevenue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Pro forma diluted earnings per share, which is commonly presented in initial public offerings.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph b

-Subparagraph 7

-Article 11

+ Details

Name:	us-gaap_DilutedEarningsPerShareProForma
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	duration